LOBULAR BREAST CARCINOMA
Clinical trials for LOBULAR BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOBULAR BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for LOBULAR BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare breast cancer
Disease control CompletedThis study tested a combination of two drugs, crizotinib and fulvestrant, in 33 people with advanced lobular breast cancer that had lost a protein called E-cadherin. It also tested crizotinib alone in people with diffuse gastric cancer, triple-negative lobular breast cancer, or o…
Matched conditions: LOBULAR BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Gene study reveals hidden breast cancer risks in young women
Knowledge-focused CompletedThis study looked at 421 women with lobular breast cancer to see how often they have changes in the CDH1 gene. The goal was to understand if these gene changes raise the risk for breast cancer, especially in women diagnosed at a young age or in both breasts. Researchers collected…
Matched conditions: LOBULAR BREAST CARCINOMA
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC